Trump Administration Outlines Sweeping Overhaul of Federal Research Funding and Scientific Priorities

The Trump administration has unveiled a comprehensive and controversial plan to fundamentally restructure how the United States government allocates billions of dollars in scientific research funding. In a series of memos and legislative proposals, administration officials have signaled a decisive shift away from traditional university-based research in favor of private-sector innovation and individual-led projects. The overhaul, led by Michael Kratsios, the President’s science adviser, and Russell Vought, Director of the Office of Management and Budget (OMB), seeks to dismantle long-standing academic norms, including the peer-review process and the current system of institutional overhead reimbursement.

This strategic pivot aims to reorient the nation’s scientific focus toward specific high-tech sectors deemed vital for national security and economic dominance, most notably artificial intelligence (AI), robotics, and nuclear energy. However, the move has ignited a firestorm of criticism from the academic community and scientific advocacy groups, who warn that the plan could compromise scientific independence and devastate the financial stability of the nation’s leading research universities.

A New Hierarchy of Scientific Priorities

At the heart of the administration’s vision is a radical reallocation of resources. During a recent House hearing, Kratsios detailed a plan to funnel federal dollars toward private companies and individual researchers, effectively bypassing the large university systems that have served as the backbone of American research for decades. This shift is accompanied by a change in thematic focus; the administration intends to scale back investment in the life sciences—a field that has traditionally received the lion’s share of federal funding through the National Institutes of Health (NIH)—to prioritize "industries of the future."

The centerpiece of this new direction is the "Genesis Mission." Established by a November executive order, the Genesis Mission is designed to integrate AI into every facet of the nation’s scientific research apparatus. According to the administration, the goal is to use machine learning and automated systems to accelerate discovery, moving from a slow, human-centric model to a high-velocity, data-driven framework. Proponents argue this will ensure the United States remains competitive with global rivals, particularly China, in the race for technological supremacy.

Reforming the Grant System: Portability and "Golden Tickets"

The administration’s memo to federal agencies introduces significant changes to how grants are awarded and managed. One of the most prominent proposals is the push for "grant portability." Currently, many federal grants are tied to the institution where the researcher is employed. Under the new directive, the administration wants to make it easier for individual researchers to move their funding between institutions. Officials argue this will create a competitive "free market" for talent, forcing universities to compete for elite researchers by offering better facilities and less administrative interference.

The administration cited the National Science Foundation’s (NSF) Graduate Research Fellowship Program as a model, where funding follows the student rather than being anchored to a specific university department.

Furthermore, the administration is seeking to overhaul the peer-review process, which has traditionally relied on panels of independent experts to evaluate the scientific merit of proposals. Kratsios has proposed a "broader menu" of review options, including a "golden ticket" system. Inspired by experimental models in Denmark, this system would allow individual reviewers to approve a high-risk, high-reward project even if the rest of the panel lacks consensus. While the administration frames this as a way to "rescue" transformative breakthroughs that might be too radical for traditional panels, critics fear it opens the door to favoritism and the erosion of rigorous scientific standards.

Perhaps most controversially, the administration has proposed regulations that would grant political appointees the final authority to approve certain awards. This move has been met with overwhelming opposition from the scientific community, who argue that science should be insulated from political ideology.

The Battle Over "Administrative Bloat" and Indirect Costs

A major pillar of the Trump administration’s plan is a direct assault on the financial structure of university research. Kratsios has repeatedly criticized what he describes as "administrative bloat" within academia, arguing that universities extract excessive "overhead" from federal grants.

In the world of federal research, these are known as "indirect costs." They fund the essential infrastructure required for research, including laboratory maintenance, high-tech equipment, utilities, security, and administrative support. Currently, the average indirect cost rate negotiated by institutions with the NIH stands at approximately 58%. This means for every dollar awarded for direct research, the government provides an additional 58 cents to the university to cover facilities and administration.

The Trump administration has attempted to cap these rates at a flat 15% across several federal agencies. When the administration first proposed this cap in 2024 and 2025, it was met with widespread alarm. University leaders argued that such a drastic reduction would make it impossible to maintain sophisticated laboratories, potentially leading to the closure of research facilities and a "brain drain" of American scientists to other countries.

While federal judges and Congress have previously blocked these caps, the latest memo from Vought and Kratsios reiterates the administration’s intent to "rein in" these costs. The administration argues that by cutting overhead, more money can be directed to the actual "bench science" and the researchers themselves, rather than toward university administrators.

Addressing "Salami-Slicing" and the Tenure Model

The administration’s report also takes aim at the culture of modern academia, specifically the pressure to publish frequently to obtain tenure. Kratsios used the term "salami-slicing" to describe the practice of researchers breaking their work into the "smallest publishable units" to inflate their publication counts.

"Cutting work into the smallest publishable units often pays off more than making an ambitious attempt at transformative discovery," Kratsios wrote. The administration argues that the current tenure-track system encourages safe, incremental research rather than the high-stakes projects that lead to true innovation. To counter this, the administration is directing agencies to expand the number of long-duration grants—those lasting five years or more—to give researchers the stability needed to pursue more ambitious goals without the constant pressure of grant renewal cycles.

Reactions from the Academic and Scientific Community

The response from labor leaders and academic organizations has been swift and overwhelmingly negative. Todd Wolfson, president of the American Association of University Professors (AAUP), and Randi Weingarten, president of the American Federation of Teachers (AFT), issued a joint statement condemning the plan as a "radical" overreach.

"We agree that our research enterprise faces serious challenges. But reforms must strengthen scientific independence—not weaken it," the statement read. "Research priorities must be guided by scientific expertise, rigorous peer review, transparency, and the public interest—not by political ideology, short-term commercial incentives, or the preferences of any administration."

Many in the scientific community are particularly concerned about the shift away from life sciences. With an aging population and the constant threat of emerging pathogens, researchers argue that cutting funding for biological and medical research could have dire consequences for public health. They also point out that many of the breakthroughs in AI and robotics actually rely on fundamental research conducted in university settings, and that undermining these institutions could eventually dry up the pipeline of innovation that the private sector relies upon.

Chronology of the Research Overhaul

The current proposals are the culmination of a multi-year effort by the Trump administration to reshape the federal scientific landscape:

• November 2025: President Trump signs an executive order launching the "Genesis Mission," prioritizing AI-driven research and establishing a framework for inter-agency cooperation on emerging technologies.
• Early 2026: The administration attempts to implement a 15% cap on indirect research costs at the NIH and NSF. The move is immediately challenged in federal court by a coalition of research universities.
• Spring 2026: Congressional leaders include language in a spending bill that temporarily bars the administration from capping indirect cost rates, citing the need for a comprehensive study on the impact of such a change.
• July 2026: Michael Kratsios testifies before the House, outlining the broader vision of moving funding toward private entities and the "golden ticket" review system.
• Current Directives: The OMB and the White House Office of Science and Technology Policy (OSTP) issue a formal memo to the heads of executive departments and agencies, instructing them to incorporate these new priorities into their Fiscal Year 2028 budget submissions.

Implications for the Future of US Innovation

The administration’s plan represents a fundamental gamble on the nature of discovery. By shifting resources to the private sector and individuals, the government is betting that market-driven incentives and "high-risk" individual breakthroughs will yield faster results than the traditional, consensus-based academic model.

However, the risks are substantial. If universities cannot afford to maintain their infrastructure due to overhead caps, the nation’s capacity for basic research—the kind of curiosity-driven science that often takes decades to yield commercial results—could be severely diminished. Furthermore, the introduction of political appointees into the grant-approval process threatens to turn scientific funding into a tool of political patronage, potentially sidelining projects that are scientifically sound but politically unpopular.

As the administration moves forward with these directives, the battle over the future of American science is likely to move from the halls of the White House to the floor of Congress and the chambers of federal courts. The outcome will determine not only how billions of dollars are spent, but also the very direction of American technological and medical progress for the next generation.